Life-saving implantable cardioverter defibrillator therapy in cardiac AL amyloidosis
Author:
Publisher
BMJ
Subject
General Medicine
Reference11 articles.
1. Bortezomib with or without dexamethasone in primary systemic (light chain) amyloidosis;Kastritis;J Clin Oncol,2010
2. Lenalidomide and dexamethasone in the treatment of AL amyloidosis: results of a phase 2 trial;Sanchorawala;Blood,2007
3. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: a staging system for primary systemic amyloidosis;Dispenzieri;J Clin Oncol,2004
4. Revised prognostic staging system for light chain amyloidosis incorporating cardiac biomarkers and serum free light chain measurements;Kumar;J Clin Oncol,2012
5. A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis;Wechalekar;Blood,2013
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Diagnosis and treatment of AL amyloidosis in 2022;Canadian Hematology Today;2022-03-01
2. Diagnosis and supportive therapeutic management of cardiac light chain amyloidosis—a cardiologist’s perspective;memo - Magazine of European Medical Oncology;2021-01-22
3. Diagnosis and treatment of cardiac amyloidosis: position statement of the German Cardiac Society (DGK);Clinical Research in Cardiology;2021-01-18
4. Cardiac Care of Patients with Cardiac Amyloidosis;Acta Haematologica;2020
5. 2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy;Heart Rhythm;2019-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3